Korea (Republic of)

Korea (Republic of)

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.15 (2.67 - 3.75) 2015 Modelled WHO
2.4 (2.30 - 3) 2016 Modelled Razavi-Shearer et al, 2018
4.36 (4.36 - 4.37) 2013 Modelled Schweitzer et al, 2015
2.95 (2.81 - 3.10) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.46 (3.31 - 3.62) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (3.38 - 3.74) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.53 (3.38 - 3.71) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.5 (3.33 - 3.68) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.52 (3.36 - 3.70) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.6 (3.43 - 3.77) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.69 (3.51 - 3.88) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.77 (3.59 - 3.97) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.79 (3.61 - 4.02) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.82 (3.64 - 4.02) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.88 (3.71 - 4.07) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.96 (3.80 - 4.15) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4.03 (3.85 - 4.22) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4.06 (3.86 - 4.26) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4.1 (3.91 - 4.30) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4.2 (4 - 4.41) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.32 (4.11 - 4.55) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.43 (4.19 - 4.68) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.49 (4.23 - 4.76) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.55 (4.29 - 4.83) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.67 (4.40 - 4.95) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.81 (4.52 - 5.12) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.93 (4.62 - 5.27) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5.02 (4.69 - 5.38) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5.1 (4.78 - 5.46) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5.23 (4.89 - 5.59) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5.39 (5.03 - 5.77) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5.57 (5.17 - 5.96) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5.74 (5.32 - 6.18) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.25 (3.10 - 3.42) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.69 (0.49 - 0.94) 2015 Modelled WHO
0.1 2014 Survey/reported WHO WPRO, Woodring J et al, 2017
0.1 (0.08 - 0.13) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.15 (0.11 - 0.19) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.20) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.20) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.20) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.20) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.21) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.12 - 0.22) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.13 - 0.23) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.15 - 0.25) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.16 - 0.28) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.24 (0.18 - 0.30) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.27 (0.20 - 0.35) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.23 - 0.40) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.36 (0.27 - 0.46) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.31 - 0.53) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.37 - 0.63) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.45 - 0.78) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.53 - 0.93) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.59 - 1.04) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.61 - 1.09) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.60 - 1.04) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.55 - 0.95) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.49 - 0.84) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.44 - 0.75) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.41 - 0.72) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.43 - 0.74) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.49 - 0.84) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.58 - 0.98) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.68 - 1.18) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.81 - 1.41) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.08 - 0.12) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,244,000 (1,155,000 - 1,502,000) 2016 Modelled Razavi-Shearer et al, 2018
1,574,690 (1,499,110 - 1,657,840) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1,659,780 (1,583,540 - 1,744,290) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,758,070 (1,680,160 - 1,842,130) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,793,520 (1,705,300 - 1,882,390) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,763,180 (1,685,330 - 1,848,040) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,728,800 (1,644,240 - 1,815,370) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,720,580 (1,640,560 - 1,805,760) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,738,630 (1,657,700 - 1,822,520) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,766,570 (1,683,920 - 1,855,340) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,785,590 (1,703,580 - 1,877,600) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,782,320 (1,695,140 - 1,882,860) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,778,290 (1,697,780 - 1,870,320) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,797,090 (1,718,690 - 1,882,070) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,825,330 (1,747,580 - 1,908,240) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,847,100 (1,764,330 - 1,933,070) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,851,030 (1,760,800 - 1,944,580) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,859,470 (1,773,490 - 1,949,450) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,894,130 (1,807,530 - 1,985,880) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,939,750 (1,849,080 - 2,039,470) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,978,590 (1,878,620 - 2,090,460) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,995,990 (1,881,890 - 2,116,090) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,012,540 (1,898,580 - 2,132,750) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,051,130 (1,934,180 - 2,174,370) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,099,670 (1,974,760 - 2,232,720) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,143,190 (2,010,760 - 2,286,740) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,170,150 (2,031,470 - 2,321,950) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,197,350 (2,057,480 - 2,351,540) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,243,070 (2,099,700 - 2,396,890) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,301,000 (2,148,220 - 2,459,670) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,361,940 (2,194,130 - 2,528,180) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,417,130 (2,236,340 - 2,599,060) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
21.7 (18.50 - 25.20) 2019 Modelled IHME, GBD 2019 (accessed 2020)
23.3 (20.44 - 26.33) 1990 Modelled IHME, GBD 2019 (accessed 2022)
21.95 (19.29 - 24.80) 1991 Modelled IHME, GBD 2019 (accessed 2022)
20.57 (18.09 - 23.25) 1992 Modelled IHME, GBD 2019 (accessed 2022)
19.52 (17.15 - 22.10) 1993 Modelled IHME, GBD 2019 (accessed 2022)
18.92 (16.59 - 21.50) 1994 Modelled IHME, GBD 2019 (accessed 2022)
18.44 (16.12 - 20.99) 1995 Modelled IHME, GBD 2019 (accessed 2022)
18.95 (16.69 - 21.48) 1996 Modelled IHME, GBD 2019 (accessed 2022)
20.3 (18.12 - 22.81) 1997 Modelled IHME, GBD 2019 (accessed 2022)
22.41 (20.18 - 24.85) 1998 Modelled IHME, GBD 2019 (accessed 2022)
24.26 (21.90 - 26.78) 1999 Modelled IHME, GBD 2019 (accessed 2022)
25.62 (23.22 - 28.06) 2000 Modelled IHME, GBD 2019 (accessed 2022)
25.96 (23.66 - 28.36) 2001 Modelled IHME, GBD 2019 (accessed 2022)
25.94 (23.55 - 28.23) 2002 Modelled IHME, GBD 2019 (accessed 2022)
25.59 (23.20 - 27.87) 2003 Modelled IHME, GBD 2019 (accessed 2022)
24.9 (22.46 - 27.15) 2004 Modelled IHME, GBD 2019 (accessed 2022)
23.39 (21.03 - 25.61) 2006 Modelled IHME, GBD 2019 (accessed 2022)
24.04 (21.69 - 26.31) 2005 Modelled IHME, GBD 2019 (accessed 2022)
22.99 (20.62 - 25.27) 2007 Modelled IHME, GBD 2019 (accessed 2022)
22.7 (20.31 - 24.99) 2008 Modelled IHME, GBD 2019 (accessed 2022)
22.23 (19.74 - 24.85) 2010 Modelled IHME, GBD 2019 (accessed 2022)
22.47 (20.03 - 24.92) 2009 Modelled IHME, GBD 2019 (accessed 2022)
21.85 (19.32 - 24.47) 2011 Modelled IHME, GBD 2019 (accessed 2022)
21.51 (18.98 - 24.10) 2012 Modelled IHME, GBD 2019 (accessed 2022)
20.81 (18.27 - 23.21) 2014 Modelled IHME, GBD 2019 (accessed 2022)
21.11 (18.60 - 23.74) 2013 Modelled IHME, GBD 2019 (accessed 2022)
21.07 (18.14 - 23.99) 2017 Modelled IHME, GBD 2019 (accessed 2022)
20.6 (18.03 - 23.08) 2015 Modelled IHME, GBD 2019 (accessed 2022)
20.56 (17.91 - 23.13) 2016 Modelled IHME, GBD 2019 (accessed 2022)
21.7 (18.46 - 25.20) 2019 Modelled IHME, GBD 2019 (accessed 2022)
21.34 (18.27 - 24.56) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
11,974 2016 Modelled WHO
11,589 (9,858 - 13,457) 2019 Modelled IHME, GBD 2019 (accessed 2020)
10,332 (9,064 - 11,673) 1990 Modelled IHME, GBD 2019 (accessed 2022)
9,804 (8,614 - 11,075) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9,240 (8,124 - 10,443) 1992 Modelled IHME, GBD 2019 (accessed 2022)
8,568 (7,513 - 9,739) 1994 Modelled IHME, GBD 2019 (accessed 2022)
8,805 (7,738 - 9,969) 1993 Modelled IHME, GBD 2019 (accessed 2022)
8,662 (7,628 - 9,817) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8,386 (7,331 - 9,543) 1995 Modelled IHME, GBD 2019 (accessed 2022)
10,363 (9,331 - 11,491) 1998 Modelled IHME, GBD 2019 (accessed 2022)
9,332 (8,326 - 10,482) 1997 Modelled IHME, GBD 2019 (accessed 2022)
11,286 (10,185 - 12,455) 1999 Modelled IHME, GBD 2019 (accessed 2022)
11,987 (10,863 - 13,127) 2000 Modelled IHME, GBD 2019 (accessed 2022)
12,207 (11,124 - 13,334) 2001 Modelled IHME, GBD 2019 (accessed 2022)
12,138 (11,008 - 13,223) 2003 Modelled IHME, GBD 2019 (accessed 2022)
12,254 (11,125 - 13,333) 2002 Modelled IHME, GBD 2019 (accessed 2022)
11,863 (10,699 - 12,934) 2004 Modelled IHME, GBD 2019 (accessed 2022)
11,501 (10,379 - 12,588) 2005 Modelled IHME, GBD 2019 (accessed 2022)
11,247 (10,113 - 12,314) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11,113 (9,966 - 12,215) 2007 Modelled IHME, GBD 2019 (accessed 2022)
11,037 (9,877 - 12,150) 2008 Modelled IHME, GBD 2019 (accessed 2022)
11,001 (9,805 - 12,198) 2009 Modelled IHME, GBD 2019 (accessed 2022)
10,875 (9,618 - 12,180) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10,969 (9,740 - 12,260) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10,811 (9,539 - 12,111) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10,718 (9,441 - 12,050) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10,741 (9,354 - 12,080) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10,669 (9,369 - 11,901) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10,668 (9,336 - 11,951) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11,094 (9,552 - 12,632) 2017 Modelled IHME, GBD 2019 (accessed 2022)
11,318 (9,691 - 13,027) 2018 Modelled IHME, GBD 2019 (accessed 2022)
11,589 (9,858 - 13,457) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
94 (75 - 117) 1990 Modelled IHME, GBD 2019 (accessed 2022)
89 (72 - 109) 1991 Modelled IHME, GBD 2019 (accessed 2022)
86 (72 - 102) 1992 Modelled IHME, GBD 2019 (accessed 2022)
84 (71 - 98) 1993 Modelled IHME, GBD 2019 (accessed 2022)
83 (72 - 95) 1994 Modelled IHME, GBD 2019 (accessed 2022)
83 (72 - 93) 1995 Modelled IHME, GBD 2019 (accessed 2022)
134 (119 - 149) 1997 Modelled IHME, GBD 2019 (accessed 2022)
182 (161 - 202) 1998 Modelled IHME, GBD 2019 (accessed 2022)
99 (87 - 111) 1996 Modelled IHME, GBD 2019 (accessed 2022)
228 (202 - 252) 1999 Modelled IHME, GBD 2019 (accessed 2022)
268 (237 - 297) 2000 Modelled IHME, GBD 2019 (accessed 2022)
293 (258 - 326) 2001 Modelled IHME, GBD 2019 (accessed 2022)
305 (269 - 339) 2002 Modelled IHME, GBD 2019 (accessed 2022)
309 (273 - 344) 2003 Modelled IHME, GBD 2019 (accessed 2022)
310 (274 - 346) 2004 Modelled IHME, GBD 2019 (accessed 2022)
306 (270 - 342) 2005 Modelled IHME, GBD 2019 (accessed 2022)
305 (269 - 342) 2006 Modelled IHME, GBD 2019 (accessed 2022)
303 (265 - 340) 2007 Modelled IHME, GBD 2019 (accessed 2022)
301 (265 - 337) 2008 Modelled IHME, GBD 2019 (accessed 2022)
298 (261 - 335) 2009 Modelled IHME, GBD 2019 (accessed 2022)
292 (253 - 330) 2010 Modelled IHME, GBD 2019 (accessed 2022)
286 (248 - 322) 2011 Modelled IHME, GBD 2019 (accessed 2022)
280 (242 - 317) 2012 Modelled IHME, GBD 2019 (accessed 2022)
276 (239 - 314) 2013 Modelled IHME, GBD 2019 (accessed 2022)
272 (235 - 312) 2014 Modelled IHME, GBD 2019 (accessed 2022)
268 (232 - 308) 2015 Modelled IHME, GBD 2019 (accessed 2022)
264 (224 - 305) 2016 Modelled IHME, GBD 2019 (accessed 2022)
259 (218 - 301) 2017 Modelled IHME, GBD 2019 (accessed 2022)
254 (210 - 297) 2018 Modelled IHME, GBD 2019 (accessed 2022)
247 (202 - 293) 2019 Modelled IHME, GBD 2019 (accessed 2022)
54 (46 - 63) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
92 2019 Survey/reported WHO/UNICEF
91 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
92 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
92 2014 Survey/reported WHO/UNICEF
92 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
98 2019 Survey/reported WHO/UNICEF
98 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2001
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.5 (0.30 - 0.50) 2015 Modelled Blach et al, 2017
0.64 (0.52 - 0.79) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.52 - 0.77) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.51 - 0.75) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.49 - 0.71) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.46 - 0.68) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.53 (0.44 - 0.65) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.51 (0.42 - 0.62) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.41 - 0.59) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.48 (0.39 - 0.57) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.38 - 0.56) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.39 - 0.57) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.42 - 0.59) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.45 - 0.64) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.48 - 0.67) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.50 - 0.70) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.51 - 0.71) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.51 - 0.73) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.52 - 0.73) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.53 - 0.74) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.53 - 0.75) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.55 - 0.77) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.57 - 0.79) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.60 - 0.82) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.61 - 0.83) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.61 - 0.84) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.60 - 0.82) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.59 - 0.81) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.57 - 0.79) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.55 - 0.77) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.52 - 0.74) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.48 - 0.74) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.28 (0.18 - 0.32) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.7 1992 Survey/reported Kim YS et al, 1992
0.8 (0.20 - 2.10) 2014 Survey/reported Gower et al, 2014
Showing out of
Show more
Newborns
Download
Value (%) Year Type Source
1.3 2019 Modelled Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
4.1 (2.20 - 6.80) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
48.4 (42.80 - 54.10) 2010 Survey/reported Min JA et al, 2013
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
4.1 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
231,000 (148,000 - 261,000) 2015 Modelled Blach et al, 2017
262,182 (219,937 - 309,192) 1990 Modelled IHME, GBD 2019 (accessed 2022)
276,450 (232,501 - 324,080) 1991 Modelled IHME, GBD 2019 (accessed 2022)
288,410 (243,101 - 336,044) 1992 Modelled IHME, GBD 2019 (accessed 2022)
297,787 (250,947 - 346,311) 1993 Modelled IHME, GBD 2019 (accessed 2022)
305,249 (259,484 - 354,414) 1994 Modelled IHME, GBD 2019 (accessed 2022)
311,231 (264,243 - 360,253) 1995 Modelled IHME, GBD 2019 (accessed 2022)
312,678 (266,794 - 362,264) 1996 Modelled IHME, GBD 2019 (accessed 2022)
308,252 (260,874 - 358,979) 1997 Modelled IHME, GBD 2019 (accessed 2022)
299,807 (252,287 - 349,342) 1998 Modelled IHME, GBD 2019 (accessed 2022)
290,818 (244,105 - 340,613) 1999 Modelled IHME, GBD 2019 (accessed 2022)
284,600 (236,802 - 334,443) 2000 Modelled IHME, GBD 2019 (accessed 2022)
281,513 (235,332 - 330,616) 2001 Modelled IHME, GBD 2019 (accessed 2022)
279,601 (233,316 - 328,398) 2002 Modelled IHME, GBD 2019 (accessed 2022)
277,477 (231,614 - 327,313) 2003 Modelled IHME, GBD 2019 (accessed 2022)
274,784 (230,412 - 323,152) 2004 Modelled IHME, GBD 2019 (accessed 2022)
270,731 (227,208 - 319,596) 2005 Modelled IHME, GBD 2019 (accessed 2022)
261,433 (220,435 - 308,025) 2006 Modelled IHME, GBD 2019 (accessed 2022)
247,018 (207,667 - 293,325) 2007 Modelled IHME, GBD 2019 (accessed 2022)
231,461 (194,300 - 275,308) 2008 Modelled IHME, GBD 2019 (accessed 2022)
220,130 (182,113 - 264,096) 2009 Modelled IHME, GBD 2019 (accessed 2022)
218,488 (179,176 - 264,205) 2010 Modelled IHME, GBD 2019 (accessed 2022)
225,319 (185,699 - 271,018) 2011 Modelled IHME, GBD 2019 (accessed 2022)
235,507 (195,393 - 284,412) 2012 Modelled IHME, GBD 2019 (accessed 2022)
247,518 (204,378 - 299,184) 2013 Modelled IHME, GBD 2019 (accessed 2022)
260,805 (215,295 - 317,257) 2014 Modelled IHME, GBD 2019 (accessed 2022)
274,368 (225,248 - 336,716) 2015 Modelled IHME, GBD 2019 (accessed 2022)
294,031 (243,695 - 355,748) 2016 Modelled IHME, GBD 2019 (accessed 2022)
312,427 (257,759 - 377,889) 2017 Modelled IHME, GBD 2019 (accessed 2022)
321,229 (264,307 - 390,238) 2018 Modelled IHME, GBD 2019 (accessed 2022)
328,648 (267,766 - 402,024) 2019 Modelled IHME, GBD 2019 (accessed 2022)
319,416 (258,929 - 392,964) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
34,000 (21,800 - 38,300) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
6.91 (5.20 - 8.70) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.93 (3.09 - 4.99) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (3.19 - 5.01) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.06 (3.27 - 5.05) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.13 (3.35 - 5.14) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.22 (3.42 - 5.21) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.34 (3.53 - 5.32) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.22 (3.42 - 5.18) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.64 (3.79 - 5.64) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5.13 (4.19 - 6.20) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5.54 (4.54 - 6.66) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5.84 (4.75 - 7.03) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5.95 (4.81 - 7.18) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.01 (4.85 - 7.28) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5.98 (4.79 - 7.26) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5.87 (4.70 - 7.16) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5.68 (4.55 - 6.96) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5.68 (4.53 - 6.91) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5.7 (4.50 - 7) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.7 (4.52 - 6.94) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.76 (4.50 - 7.11) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.73 (4.49 - 7.05) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.78 (4.51 - 7.17) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.86 (4.57 - 7.28) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.9 (4.59 - 7.34) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5.96 (4.65 - 7.40) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6.04 (4.70 - 7.50) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6.45 (4.93 - 8.02) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6.17 (4.79 - 7.68) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6.67 (5.05 - 8.32) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6.91 (5.20 - 8.70) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,938 2016 Modelled WHO
3,689 (2,778 - 4,647) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3,689 (2,778 - 4,647) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3,537 (2,681 - 4,414) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3,398 (2,596 - 4,223) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3,223 (2,499 - 4,011) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3,129 (2,433 - 3,882) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3,054 (2,386 - 3,794) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2,993 (2,330 - 3,725) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2,944 (2,298 - 3,656) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,879 (2,244 - 3,568) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,843 (2,221 - 3,507) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,803 (2,198 - 3,451) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,774 (2,187 - 3,402) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2,753 (2,185 - 3,352) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,730 (2,180 - 3,322) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2,718 (2,176 - 3,329) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,796 (2,238 - 3,410) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,838 (2,271 - 3,445) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2,840 (2,293 - 3,438) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,798 (2,262 - 3,377) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,732 (2,221 - 3,290) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,575 (2,111 - 3,097) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,371 (1,938 - 2,868) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,135 (1,741 - 2,591) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,983 (1,612 - 2,431) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,918 (1,553 - 2,357) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,911 (1,551 - 2,359) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,862 (1,511 - 2,319) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,822 (1,470 - 2,268) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,786 (1,424 - 2,236) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,743 (1,369 - 2,211) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
21 (14 - 29) 1990 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 28) 1991 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 27) 1992 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 27) 1993 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 26) 1994 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 26) 1995 Modelled IHME, GBD 2019 (accessed 2022)
32 (23 - 40) 1997 Modelled IHME, GBD 2019 (accessed 2022)
24 (17 - 30) 1996 Modelled IHME, GBD 2019 (accessed 2022)
43 (32 - 55) 1998 Modelled IHME, GBD 2019 (accessed 2022)
54 (40 - 69) 1999 Modelled IHME, GBD 2019 (accessed 2022)
63 (46 - 81) 2000 Modelled IHME, GBD 2019 (accessed 2022)
69 (51 - 89) 2001 Modelled IHME, GBD 2019 (accessed 2022)
73 (54 - 94) 2003 Modelled IHME, GBD 2019 (accessed 2022)
73 (54 - 95) 2004 Modelled IHME, GBD 2019 (accessed 2022)
72 (53 - 93) 2002 Modelled IHME, GBD 2019 (accessed 2022)
72 (53 - 94) 2005 Modelled IHME, GBD 2019 (accessed 2022)
75 (55 - 97) 2006 Modelled IHME, GBD 2019 (accessed 2022)
77 (56 - 100) 2007 Modelled IHME, GBD 2019 (accessed 2022)
79 (57 - 101) 2008 Modelled IHME, GBD 2019 (accessed 2022)
80 (59 - 104) 2010 Modelled IHME, GBD 2019 (accessed 2022)
80 (58 - 102) 2009 Modelled IHME, GBD 2019 (accessed 2022)
80 (59 - 104) 2011 Modelled IHME, GBD 2019 (accessed 2022)
82 (59 - 106) 2013 Modelled IHME, GBD 2019 (accessed 2022)
81 (59 - 105) 2012 Modelled IHME, GBD 2019 (accessed 2022)
82 (60 - 107) 2014 Modelled IHME, GBD 2019 (accessed 2022)
83 (60 - 109) 2015 Modelled IHME, GBD 2019 (accessed 2022)
85 (61 - 110) 2017 Modelled IHME, GBD 2019 (accessed 2022)
84 (61 - 109) 2016 Modelled IHME, GBD 2019 (accessed 2022)
86 (60 - 111) 2018 Modelled IHME, GBD 2019 (accessed 2022)
85 (59 - 112) 2019 Modelled IHME, GBD 2019 (accessed 2022)
19 (13 - 25) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2001
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
3.25 (%)
2019
(3.1 - 3.42(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
0.6 (%)
2019
(0.48 - 0.74(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV (anti-HCV)
0.8 (%)
2014
(0.2 - 2.1(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
11,589
2019
(9,858 - 13,457)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
3,689
2019
(2,778 - 4,647)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.10 (%)
2014, survey/surveillance
WHO WPRO, Woodring J et al, 2017

Prevalence PWID

HCV
48.40 (%)
2010, survey/surveillance
(42.80 - 54.10(%))
Min JA et al, 2013

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
92 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Download National Hepatitis Elimination Profile (N-HEP)

Latest news

View all

News

Resources